Studies in the liver indicate that the amount of biologically active INSR at the cytoplasmic membrane can be reduced by its cleavage by the β-site amyloid precursor protein cleaving enzyme 1 (BACE1), particularly in T2DM [296]. This evidence concerns the gene INSR and type 2 diabetes mellitus.